Showing results (361-370 of 590) with videos related to
Sort By:
Pageof 59
Melanoma Research|June 12, 2013
Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanomaJohn R Hyngstrom, Yi-Ju Chiang, Kate D Cromwell, et al.Cancer|June 22, 2010
Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatmentAlexandra S Brown, Kelly K Hunt, Jeannie Shen, et al.Annals of Surgical Oncology|March 22, 2001
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomasC M Balch, S J Soong, T Smith, et al.Cancer|March 5, 2005
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistryAnees Chagpar, Lavinia P Middleton, Aysegul A Sahin, et al.Annals of Surgical Oncology|April 15, 2006
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumorGildy V Babiera, Roshni Rao, Lei Feng, et al.Annals of Surgical Oncology|May 26, 2005
Paget's disease of the breast: there is a role for breast-conserving therapyKazumi Kawase, Dominick J Dimaio, Susan L Tucker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2002
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanomaMatthew T Ballo, Jeffrey E Gershenwald, Gunar K Zagars, et al.The Journal of Investigative Dermatology|September 23, 2006
Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanomaChunying Li, Zhensheng Liu, Zhengdong Zhang, et al.Journal of the American College of Surgeons|February 21, 2012
A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer modelGlenda G Callender, Jeffrey E Gershenwald, Michael E Egger, et al.Scientific Reports|November 16, 2021
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancerMegumi Kai, Angela N Marx, Diane D Liu, et al.Pageof 59